Open AccessFractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunity
Author(s) -
Sarah Sanchez,
Nicole Palacio,
Tanushree Dangi,
Thomas Ciucci,
Pablo PenalozaMacMaster
Publication year - 2021
Publication title -
science immunology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 8.83
H-Index - 51
ISSN - 2470-9468
DOI - 10.1126/sciimmunol.abi8635
Subject(s) - virology , immunity , immune system , immunology , medicine , vaccination , virus , pandemic , vaccine efficacy , biology , covid-19 , infectious disease (medical specialty) , disease
Reducing the priming dose of an SARS-CoV-2 Ad5-based vaccine improves cellular and humoral responses against SARS-CoV-2.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom